Company / Free Cash Flow per Share
Apellis Pharmaceuticals, Inc. Free Cash Flow per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$0.36
FY2025
5-year range
-$7.41 / $0.36
FY2021-FY2025
Trend
+149.0%
vs FY2024
Sector context
#61 of 192
Health Care
What the data says
At $0.36, Apellis Pharmaceuticals, Inc.'s free cash flow per share ranks #61 of 192 in the Health Care sector. Free Cash Flow per Share has fluctuated over the past 7 years, ranging from $-7.41 in FY2021 to $0.36 in FY2025.
Based on SEC 10-K filings.
0.36 in FY2025.
Improved from $-5.38 to $0.36 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#61 of 192 in Health CareTop 32% of 192This company $0.36 Sector average -$19.84
▼
+101.8% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 149.0% year-over-year.
- Ranks #61 out of 192 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -25.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.36 | +149.0% |
| FY2024 | -$0.74 | +86.3% |
| FY2023 | -$5.38 | -1.8% |
| FY2022 | -$5.28 | +28.7% |
| FY2021 | -$7.41 | -185.6% |
| FY2020 | -$2.59 | +24.1% |
| FY2019 | -$3.42 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026